No Data
No Data
It's Time to Get Your Covid and Flu Shots. Everything to Know About This Year's Vaccines. -- Barrons.com
The Market Doesn't Like What It Sees From Novavax, Inc.'s (NASDAQ:NVAX) Revenues Yet As Shares Tumble 25%
Express News | Novavax Inc: U.S. Cdc and Acip Recommend Additional Covid-19 Vaccine Dose for Older Individuals and Those Who Are Immunocompromised
Express News | CDC Issues Report On Missouri H5N1 Serology Testing; Confirms No Human-To-Human Transmission Of H5 Bird Flu Detected In US
U.S. CDC and ACIP Recommend Additional COVID-19 Vaccine Dose for Older Individuals and Those Who Are Immunocompromised
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?
No Data
No Data
Stock Winner : No
Dafydd Green : That won’t happen. The recent slump is to do with one FDA pause on a trial - and is very likely to restart again soon. The restart will cause a price surge and draw attention again to its influenza portfolio - which is strong. Bears, I don’t think there’s much left to squeeze here